Literature DB >> 22452290

Xenobiotic-induced liver injury and fibrosis.

Christoph H Österreicher1, Michael Trauner.   

Abstract

INTRODUCTION: Many different drugs and xenobiotics (chemical compounds foreign to an organism) can injure the bile duct epithelium and cause inflammatory bile duct diseases (cholangiopathies) ranging from transient cholestasis to vanishing bile duct syndrome, sclerosing cholangitis with development of biliary fibrosis and cirrhosis. Animal models of xenobiotic-induced liver injury have provided major mechanistic insights into the molecular mechanisms of xenobiotic-induced cholangiopathies and biliary fibrosis including primary biliary cirrhosis and primary sclerosing cholangitis. AREAS COVERED: In this review, the authors discuss the basic principles of xenobiotic-induced liver and bile duct injury and biliary fibrosis with emphasis on animal models. A PubMed search was performed using the search terms "xenobiotic," "liver injury," "cholestasis," and "biliary fibrosis." Reference lists of retrieved articles were also searched for relevant literature. EXPERT OPINION: Xenobiotic-induced cholangiopathies are underestimated and frequently overlooked medical conditions due to their often transient nature. However, biliary disease may progress to vanishing bile duct syndrome, biliary fibrosis, and cirrhosis. Moreover, xenobiotics may prime the liver for subsequent liver disease by other agents and may also contribute to the development of hepatobiliary cancer though interaction with resident stem cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22452290     DOI: 10.1517/17425255.2012.674511

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  5 in total

1.  An ω-3-enriched diet alone does not attenuate CCl4-induced hepatic fibrosis.

Authors:  Todd R Harris; Sean Kodani; Jun Yang; Denise M Imai; Bruce D Hammock
Journal:  J Nutr Biochem       Date:  2016-09-14       Impact factor: 6.048

2.  Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice.

Authors:  Liou Y Sun; Adam Spong; William R Swindell; Yimin Fang; Cristal Hill; Joshua A Huber; Jacob D Boehm; Reyhan Westbrook; Roberto Salvatori; Andrzej Bartke
Journal:  Elife       Date:  2013-10-29       Impact factor: 8.140

3.  Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma.

Authors:  Meiyi Li; Chen Li; Wei-Xin Liu; Conghui Liu; Jingru Cui; Qingrun Li; Hong Ni; Yingcheng Yang; Chaochao Wu; Chunlei Chen; Xing Zhen; Tao Zeng; Mujun Zhao; Lei Chen; Jiarui Wu; Rong Zeng; Luonan Chen
Journal:  J Mol Cell Biol       Date:  2017-12-01       Impact factor: 6.216

4.  Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.

Authors:  Kyung-Hyun Kim; Hyun-Jung Sung; Woo-Ram Lee; Hyun-Jin An; Jung-Yeon Kim; Sok Cheon Pak; Sang-Mi Han; Kwan-Kyu Park
Journal:  Toxins (Basel)       Date:  2015-08-25       Impact factor: 4.546

5.  Longevity is impacted by growth hormone action during early postnatal period.

Authors:  Liou Y Sun; Yimin Fang; Amit Patki; Jacob Je Koopman; David B Allison; Cristal M Hill; Michal M Masternak; Justin Darcy; Jian Wang; Samuel McFadden; Andrzej Bartke
Journal:  Elife       Date:  2017-07-04       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.